Industries > Pharma > Single-Use Bioreactors Market Report 2021-2031

Single-Use Bioreactors Market Report 2021-2031

Forecasts by Capacity (Up to 10L, 11–100L, 101–500L, 501–1500L, Above 1500L), by Components (Media Bags (2D/3D), Single-Use Vessels, Tubing and Connectors, Filtration Assemblies), by Molecule Type (Monoclonal Antibodies, Vaccines, Gene-Modified Cells, Stem Cells, Recombinant Proteins, Other), by SUB Type (Stirred-Tank SUBs, Wave-Induced SUBs, Bubble-Column SUBs), End-user, (Biopharmaceutical Companies, Contract Research Organizations (CRO), Contract Manufacturing Organizations (CMOs), Academic & Research Institutes, Other), by Application (Research and Development (R&D), Process Development, Bioproduction, Other) AND Regional and Leading National Market Analysis PLUS Analysis of Leading SUB Companies AND COVID-19 Recovery Scenarios

PUBLISHED: 10 May 2021
PAGES: 524
PRODUCT CODE: PHA1132
SUBMARKET: Biotechnology

WOOCS 2.2.1
DOWNLOAD FREE SAMPLE
SKU: PHA1132 Categories: , Tags: , , ,

Want to Know What is holding you back in the Single-Use Bioreactors Business?
Visiongain, a renowned market intelligence firm has published strategic report on ‘Global Single-Use Bioreactors Market’. This report explores the current and emerging opportunities in the single-use bioreactors market. The increasing adoption of personalized medicines for cancer is increasing the adoption of single-use technology. Personalized medicine can provide the best outcomes, highest safety margin and best patient care.

Huge Demand for Single-Use Bioreactors from Biopharmaceutical Companies
Significant adoption of single-use technology by biopharmaceutical companies and contract manufacturers has been observed. Major biopharmaceutical companies and contract manufacturers such as Dr. Reddy Laboratories and Lonza Group Ltd., Amgen Inc. and Wuxi Biologics Co. Ltd. have opened single-use manufacturing facilities in different countries. Lonza expanded its single-use manufacturing capacity in the U.K. due to an increased demand for the development of biopharmaceutical and clinical manufacturing services.

Our 520+ page report provides 342 tables, 353 charts, and graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing single-use bioreactors market. Buy our report to see how to exploit these opportunities in the global market.

Forecasts to 2031 and other analyses reveal the commercial prospects
• In addition to revenue forecasting to 2031, our new study provides you with recent results, growth rates, and market shares.
• You find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), Porter’s Five Forces Analysis, product profiles and commercial developments.

Leading companies and the potential for market growth
As per Visiongain analysis, global single-use bioreactors market is estimated to be valued at US$3.46 billion in 2021. The market is projected to reach at a market value of US$5.17 billion by 2031. We predict strong revenue growth through to 2031. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

This report includes data analysis and invaluable insight into how COVID-19 will affect your industry. Access this report today.

To access the data contained in this document please email contactus@visiongain.com

CTA

What all Segments Are Covered in the Report?

Global Single-Use Bioreactors Market by Capacity (COVID-19 Impact Recovery Analysis Covered)
• Up to 10L
• 11–100L
• 101–500L
• 501–1500L
• Above 1500L

Global Single-Use Bioreactors Market by Components (COVID-19 Impact Recovery Analysis Covered)
• Media Bags (2D/3D)
• Single-Use Vessels
• Tubing and Connectors
• Filtration Assemblies

Global Single-Use Bioreactors Market by Molecule Type (COVID-19 Impact Recovery Analysis Covered)

• Monoclonal Antibodies
• Vaccines
• Gene-Modified Cells
• Stem Cells
• Recombinant Proteins
• Other Molecule Type

Global Single-Use Bioreactors Market by SUB Type (COVID-19 Impact Recovery Analysis Covered)
• Stirred-Tank SUBs
• Wave-Induced SUBs
• Bubble-Column SUBs

Global Single-Use Bioreactors Market by End-User (COVID-19 Impact Recovery Analysis Covered)
• Biopharmaceutical Companies
• Contract Research Organizations (CRO)
• Contract Manufacturing Organizations (CMOs)
• Academic & Research Institutes
• Other End-Users

Global Single-Use Bioreactors Market by Application (COVID-19 Impact Recovery Analysis Covered)
• Research and Development (R&D)
• Process Development
• Bioproduction
• Other Applications

Global Single-Use Bioreactors Market by Region (COVID-19 Impact Recovery Analysis Covered)
• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East & Africa

Single-Use Bioreactors Market Report 2021-2031
Need industry data? Please contact us today.

How the Single-Use Bioreactors Market report helps you? Buy this report to find answers for below questions and how can help you to stay updated
• What is the current size of the overall global single-use bioreactors market? How much will this market be worth from 2021 to 2031?
• How will market shares of the leading national markets change by 2031, and which geographical region will lead the market in 2031?
• Who are the leading companies and what are their activities, results, developments and prospects?
• What are some of the most prominent single-use bioreactors currently in development?
• What are the main trends that will affect the world single-use bioreactors market between 2021 and 2031?
• What are the main strengths, weaknesses, opportunities and threats for the market?
• What are the social, technological, economic and political influences that will shape that industry over the next ten years?
• How will the global single-use bioreactors market evolve over the forecasted period, 2021 to 2031?
• Which segment can succeed and what revenues could they generate to 2031?
• What will be the main commercial drivers for the market from 2021 to 2031?
• How will market shares of prominent national markets change from 2021, and which countries will lead the market in 2031, achieving highest revenues and fastest growth?
• How will that industry evolve between 2021 and 2031, especially in R&D?

Companies Profiled in the Report
• AstraZeneca PLC
• Sartorius Stedim Biotech Sa. Ltd
• Danaher Corporation Ltd.
• Thermo Fisher Scientific Inc
• Gentinge AB Ltd.
• Merck Kgaa (Merck Millipore) Pvt.Ltd.
• PBS Biotech Pvt.Ltd.
• Distek, Inc
• G&G Technologies, Inc.
• Satake Chemical Equipment Mfg., Ltd.
• Celltainer Biotech Bv Pvt.Ltd.
• Phraj Hipurity Systems Limited (PHS)
• Shanghai Bailun Bioengineering Co., Ltd
• Bio-Age Equipment & Service Pvt.Ltd
• Electrolab Biotech Pvt.Ltd

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.

Information found nowhere else
With our newly report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain’s study is for everybody needing commercial analyses for the single-use bioreactors market and leading companies. You will find data, trends and predictions.

To access the data contained in this document please email contactus@visiongain.com

Buy our report today Single-Use Bioreactors Market Report 2021-2031: Forecasts by Capacity (Up to 10L, 11–100L, 101–500L, 501–1500L, Above 1500L), by Components (Media Bags (2D/3D), Single-Use Vessels, Tubing and Connectors, Filtration Assemblies), by Molecule Type (Monoclonal Antibodies, Vaccines, Gene-Modified Cells, Stem Cells, Recombinant Proteins, Other), by SUB Type (Stirred-Tank SUBs, Wave-Induced SUBs, Bubble-Column SUBs), End-user, (Biopharmaceutical Companies, Contract Research Organizations (CRO), Contract Manufacturing Organizations (CMOs), Academic & Research Institutes, Other), by Application (Research and Development (R&D), Process Development, Bioproduction, Other) AND Regional and Leading National Market Analysis PLUS Analysis of Leading SUB Companies AND COVID-19 Recovery Scenarios. Avoid missing out by staying informed – order our report now.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com

Download sample pages

Complete the form below to download your free sample pages for Single-Use Bioreactors Market Report 2021-2031

    Download sample pages

    Complete the form below to download your free sample pages for Single-Use Bioreactors Market Report 2021-2031

      Latest Pharma news

      Visiongain Publishes Drug Delivery Technologies Market Report 2024-2034

      The global Drug Delivery Technologies market is estimated at US$1,729.6 billion in 2024 and is projected to grow at a CAGR of 5.5% during the forecast period 2024-2034.

      23 April 2024

      READ

      Visiongain Publishes Cell Therapy Technologies Market Report 2024-2034

      The cell therapy technologies market is estimated at US$7,041.3 million in 2024 and is projected to grow at a CAGR of 10.7% during the forecast period 2024-2034.

      18 April 2024

      READ

      Visiongain Publishes Automation in Biopharma Industry Market Report 2024-2034

      The global Automation in Biopharma Industry market is estimated at US$1,954.3 million in 2024 and is projected to grow at a CAGR of 7% during the forecast period 2024-2034.

      17 April 2024

      READ

      Visiongain Publishes Anti-obesity Drugs Market Report 2024-2034

      The global Anti-obesity Drugs market is estimated at US$11,540.2 million in 2024 and is expected to register a CAGR of 21.2% from 2024 to 2034.

      12 April 2024

      READ